VPS9D1-AS1 contributes to HCC cell proliferation, migration and stemness via SEC61A1 up-regulation in a miR-491-5p-dependent way, indicating VPS9D1-AS1 as the putative therapeutic target for HCC treatment. Here, SEC61A1 is linked to hepatocellular carcinoma.